S&P 500

5.431,60

0,00%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
Europa
EU
Equasens (EQS)
Equasens (EQS) Notícias

EQS

Equasens (EQS)

Equasens

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:EU:EQS

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/06/2024	13:00	GlobeNewswire Inc.	Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS	EU:EQS	Equasens
10/06/2024	13:00	GlobeNewswire Inc.	EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES	EU:EQS	Equasens
07/05/2024	13:00	GlobeNewswire Inc.	Equasens: Q1 2024 revenue	EU:EQS	Equasens
07/05/2024	13:00	GlobeNewswire Inc.	EQUASENS : Chiffre d’affaires T1 2024	EU:EQS	Equasens
30/04/2024	13:45	GlobeNewswire Inc.	EQUASENS : Modalités de mise à disposition de l'URD 2023	EU:EQS	Equasens
29/03/2024	14:02	GlobeNewswire Inc.	Equasens: 2023 Annual Results	EU:EQS	Equasens
29/03/2024	14:02	GlobeNewswire Inc.	EQUASENS : Résultats Annuels 2023	EU:EQS	Equasens
07/02/2024	14:30	GlobeNewswire Inc.	EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE	EU:EQS	Equasens
06/02/2024	14:00	GlobeNewswire Inc.	EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€	EU:EQS	Equasens
06/02/2024	14:00	GlobeNewswire Inc.	Equasens: 2023 revenue: €219.7m, +2.6%	EU:EQS	Equasens
02/01/2024	14:00	GlobeNewswire Inc.	Equasens: Acquisition of a majority stake in DIGIPHARMACIE	EU:EQS	Equasens
02/01/2024	14:00	GlobeNewswire Inc.	EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE	EU:EQS	Equasens
27/12/2023	14:00	GlobeNewswire Inc.	EQUASENS : Evolution du Comité de Direction du Groupe Equasens	EU:EQS	Equasens
27/12/2023	14:00	GlobeNewswire Inc.	Equasens: Changes in the Equasens Group Executive Committee	EU:EQS	Equasens
23/11/2023	14:00	GlobeNewswire Inc.	EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany	EU:EQS	Equasens
23/11/2023	14:00	GlobeNewswire Inc.	EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany	EU:EQS	Equasens
09/11/2023	14:00	GlobeNewswire Inc.	EQUASENS : Chiffre d’affaires du 3ème trimestre 2023	EU:EQS	Equasens
09/11/2023	14:00	GlobeNewswire Inc.	Equasens: Q3 2023 revenue	EU:EQS	Equasens
04/10/2023	13:06	GlobeNewswire Inc.	EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023	EU:EQS	Equasens
29/09/2023	13:00	GlobeNewswire Inc.	EQUASENS : Résultats Semestriels 2023	EU:EQS	Equasens
29/09/2023	13:00	GlobeNewswire Inc.	EQUASENS: H1 2023 Results	EU:EQS	Equasens
25/09/2023	13:00	GlobeNewswire Inc.	EQUASENS : bilan du contrat de liquidité au 30 juin 2023	EU:EQS	Equasens
03/08/2023	13:00	GlobeNewswire Inc.	GROUPE EQUASENS : Chiffre d’affaires du 1er semestre 2023 en progression de 9 % à 112,62 M€	EU:EQS	Equasens
03/08/2023	13:00	GlobeNewswire Inc.	EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m	EU:EQS	Equasens
05/07/2023	13:00	GlobeNewswire Inc.	EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023	EU:EQS	Equasens
05/07/2023	13:00	GlobeNewswire Inc.	EQUASENS : résultat du vote des résolutions présentées à l’assemblée générale ordinaire annuelle du 29 juin 2023	EU:EQS	Equasens
09/06/2023	13:00	GlobeNewswire Inc.	EQUASENS: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS	EU:EQS	Equasens
11/05/2023	13:00	GlobeNewswire Inc.	EQUASENS: Q1 2023 revenue: +13.96% to €56.25m	EU:EQS	Equasens
11/05/2023	13:00	GlobeNewswire Inc.	EQUASENS : Chiffre d’affaires T1 2023 : +13,96% à 56,25 M€	EU:EQS	Equasens
04/05/2023	07:00	GlobeNewswire Inc.	EQUASENS : Mise à disposition du Document d’Enregistrement Universel 2022	EU:EQS	Equasens